Dr. Vivek Kumar, MD

Dr. Kumar practices at UPMC Williamsport in Williamsport, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Kumar's NPI, 1427190461, was assigned on February 13, 2007. Dr. Kumar holds Pennsylvania license MD445902.

Dr. Kumar's primary practice is UPMC Williamsport, at 700 High Street, Williamsport, PA 17701 in Lycoming County. The practice phone is (570) 321-1000.

Dr. Kumar's primary practice is UPMC Williamsport in Williamsport, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Kumar is also affiliated with WellSpan Evangelical Community Hospital. The medical group on file is Susquehanna Health System. Dmand AI also links Dr. Kumar to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kumar practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Kumar's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Kumar's licenses on file in 2 states: Pennsylvania and Maryland.

CMS data shows 607 Medicare services from Dr. Kumar across 16 procedure codes in 2024, for 429 Medicare patients. Medicare paid $75,379 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 429 Medicare patients who saw Dr. Kumar in 2024. The largest group is 65 to 74, with 239 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kumar's median patient age at 71, with 53% women.

In 2024, Dr. Kumar wrote 525 Medicare Part D claims for 334 patients. 90% of them were for generic drugs. CMS names the drug for 468 of them, across 12 drugs with 11 or more claims each, at $36,816 in total drug cost. In 2023, CMS named 196 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Kumar for performance year 2024, reported as part of a group. Dr. Kumar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kumar as offering telehealth. CMS counts 441 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Kumar, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 262 papers to Dr. Kumar, published from 2011 to 2025. 2020 was the busiest year, with 26. The most frequent topics are Mice, Inbred C57BL, Behavior, Animal and HEK293 Cells. Dr. Kumar has published most often in J Med Chem. Dr. Kumar's most frequent co-authors are Zain Siddiqui, MD, Mohit Garg, MD and Abhinav Binod Chandra, MD.

CMS Open Payments shows 105 general payments to Dr. Kumar from 24 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $720.